Discontinued — last reported Q4 '25
Datadog, Inc. Acquisitions increased by 1422.9% to $10.66M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 486.4%, from $1.82M to $10.66M. Over 4 years (FY 2021 to FY 2025), Acquisitions shows a downward trend with a -15.0% CAGR.
High spending indicates an aggressive growth strategy, while low spending may indicate a focus on organic growth or debt reduction.
This represents the net cash outflow for the purchase of other businesses or strategic assets, adjusted for any cash acq...
Highly variable; pharmaceutical companies frequently use M&A to offset patent cliffs and expand therapeutic portfolios.
cf_acquisitions| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $188.84M | -$146.00K | $26.30M | $4.87M | $34.70M | $736.00K | $5.58M | $0.00 | $2.03M | $4.34M | $6.13M | $0.00 | $444.00K | $210.00K | $6.48M | $1.82M | $115.27M | $192.00K | $700.00K | $10.66M |
| QoQ Change | — | -100.1% | >999% | -81.5% | +612.3% | -97.9% | +657.6% | -100.0% | — | +114.5% | +41.1% | -100.0% | — | -52.7% | >999% | -71.9% | >999% | -99.8% | +264.6% | >999% |
| YoY Change | — | — | — | — | -81.6% | +604.1% | -78.8% | -100.0% | -94.2% | +490.2% | +9.9% | — | -78.1% | -95.2% | +5.7% | — | >999% | -8.6% | -89.2% | +486.4% |